Psychometric performance of a generic walking scale (Walk-12G) in multiple sclerosis and Parkinson’s disease
Walking difficulties are common in neurological and other disorders, as well as among the elderly. There is a need for reliable and valid instruments for measuring walking difficulties in everyday life since existing gait tests are clinician rated and focus on situation specific capacity. The Walk-12G was adapted from the 12-item multiple sclerosis walking scale as a generic patient-reported rating scale for walking difficulties in everyday life. The aim of this study is to examine the psychometric properties of the Walk-12G in people with multiple sclerosis (MS) and Parkinson’s disease (PD). The Walk-12G was translated into Swedish and evaluated qualitatively among 25 people with and without various neurological and other conditions. Postal survey (MS, n = 199; PD, n = 189) and clinical (PD, n = 36) data were used to test its psychometric properties. Respondents considered the Walk-12G relevant and easy to use. Mean completion time was 3.5 min. Data completeness was good (<5% missing item responses) and tests of scaling assumptions supported summing item scores to a total score (corrected item-total correlations >0.6). Coefficient alpha and test–retest reliabilities were >0.9, and standard errors of measurement were 2.3–2.8. Construct validity was supported by correlations in accordance with a priori expectations. Results are similar to those with previous Walk-12G versions, indicating that scale adaptation was successful. Data suggest that the Walk-12G meets rating scale criteria for clinical trials, making it a valuable complement to available gait tests. Further studies involving other samples and application of modern psychometric methods are warranted to examine the scale in more detail.
KeywordsMultiple sclerosis Outcome assessment Parkinson’s disease Psychometrics Walking
The authors wish to thank the respondents, interviewees, translators and lay people for their cooperation. We are also grateful to Martina Eliasson, Jan Reimer, Klas Wictorin, Gun Jadbäck, Lars Forsgren, Mona Edström and Birgitta Wikström for assistance with data collection and sampling. The study was supported by the Swedish Research Council, the Swedish Parkinson Foundation, the Swedish Parkinson Academy, the Skane County Council Research and Development Foundation, and the Faculty of Medicine at Lund University. MHN was in part supported by the Swedish Council for Working Life and Social Research, within the context of the Centre for Ageing and Supportive Environments (CASE), Lund University, Sweden.
Conflict of interest
- 4.Shumway-Cook A, Woollacott M (2007) Motor control: translating research into clinical practice. Lippincott Williams and Wilkins, BaltimoreGoogle Scholar
- 6.Department of Health (2008) High quality care for all–NHS Next Stage Review Final Report. Department of Health, UKGoogle Scholar
- 7.Food and Drug Administration (2009) Patient-Reported Outcome measures: Use in Medicinal Product Development to Support Labelling Claims. Washington DCGoogle Scholar
- 10.Hobart J (2011) The Multiple Sclerosis Impacts Scale (MSIS-29): Initial development; subsequent revision; lessons learned. In: Jenkinson C, Peters M, Bromberg MB (eds) Quality of Life Measurement in Neurodegenerative and Related Conditions. Cambridge University Press, Cambridge, pp 24–40CrossRefGoogle Scholar
- 12.Fahn S, Elton RL (1987) Members of the UPDRS development committee Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M (eds) Recent developments in Parkinson’s disease, vol 2. MacMillan Healthcare Information, Florham Park, pp 153–163Google Scholar
- 18.Lim LI, van Wegen EE, de Goede CJ, Jones D, Rochester L, Hetherington V, Nieuwboer A, Willems AM, Kwakkel G (2005) Measuring gait and gait-related activities in Parkinson’s patients own home environment: a reliability, responsiveness and feasibility study. Parkinsonism Relat Disord 11(1):19–24PubMedCrossRefGoogle Scholar
- 24.Hobart J, Cano S (2009) Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods. Health Technol Assess 13 (12):iii, ix–x, 1–177Google Scholar
- 31.Streiner DL, Norman GR (2008) Health measurement scales: a practical guide to their development and use, 4th edn. Oxford University Press Inc., New YorkGoogle Scholar